Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Omeros Corporation (OMER) Cash Flow Statement

Omeros Corporation (OMER) generated -$68.7M of operating cash flow over the twelve months to 2026-06-30, spent $56000 on capital expenditure and had free cash flow of -$68.7M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OMEROmeros CorporationFollow OMER — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days
LineFY2011
Dec 11
FY2012
Dec 12
FY2013
Dec 13
FY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-25.7-34.6-29.7-58.0-65.2-51.5-36.2-103.7-60.1-100.1-109.7-86.574.7-148.8-116.1-68.7
Capital expenditure1.20.60.20.00.20.10.40.60.30.30.30.10.40.20.1-0.1
Free cash flow-26.9-35.2-29.9-58.1-65.4-51.6-36.6-104.3-60.4-100.4-110.0-86.674.3-149.0-116.2-68.7
Share repurchases————————————4.711.90.0—
Stock-based compensation1.94.36.38.99.613.612.711.713.814.917.614.111.710.58.2—

USD millions · SEC XBRL

Omeros Corporation — questions

What is Omeros Corporation's operating cash flow?
-$68.7M over the twelve months to 2026-06-30.
How much does Omeros Corporation spend on capital expenditure?
$56000 over the twelve months to 2026-06-30.
What is Omeros Corporation's free cash flow?
-$68.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Omeros Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.